EAM
MDCXW

Empery Asset Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Empery Asset Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5K Hold
12,100
– – 0.01% 29
2025
Q4 		$9.68K Buy
+12,100
New +$11.3K 0.01% 29

Other funds holding MDCXW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Empery Asset Management's MDCXW Position: Q1 2026 in Review

Empery Asset Management held its Medicus Pharma Warrant (MDCXW) position steady in Q1 2026 at 12,100 shares worth $11.5K. The position accounts for 0.01% of the portfolio, ranked #29.

Empery Asset Management first reported a position in MDCXW in Q4 2025 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

  • Empery Asset Management held 12,100 shares of Medicus Pharma Warrant worth $11.5K as of Q1 2026.
  • Empery Asset Management left its Medicus Pharma Warrant share count unchanged in Q1 2026.
  • Medicus Pharma Warrant made up 0.01% of Empery Asset Management's portfolio in Q1 2026, its #29 holding.
  • Empery Asset Management first reported a position in Medicus Pharma Warrant in Q4 2025 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.